Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

Theo một nghiên cứu mới đây, trẻ sinh non nhập viện tiêm vắc-xin thường quy ở tháng thứ 2 có nguy cơ xuất hiện một đợt ngưng thở trong vòng 48 giờ cao hơn so với trẻ không tiêm vắc-xin. Các nhà nghiên cứu cho biết: “Các phát hiện của chúng tôi về sự gia tăng các đợt ngưng thở sau tiêm vắc-xin ở trẻ sinh non phù hợp với những nghiên cứu quan sát trước đây và các cảnh báo có trong tờ hướng dẫn đi kèm vắc-xin.”

Vắc-xin thường quy có liên quan đến nguy cơ ngưng thở cao hơn ở trẻ sinh non nhập viện

Sử dụng glucocorticoid trước sinh khiến trẻ dễ mắc các rối loạn tâm thần

Theo một nghiên cứu đoàn hệ quy mô lớn, phụ nữ mang thai sử dụng glucocorticoid có thể khiến trẻ có nguy cơ mắc một số rối loạn tâm thần.

Sử dụng glucocorticoid trước sinh khiến trẻ dễ mắc các rối loạn tâm thần

Z-drug exposure during early pregnancy not a risk factor for congenital malformations

The use of nonbenzodiazepine sedative hypnotics (Z-drugs) for sleep dysregulation during the first trimester of pregnancy does not appear to contribute to a meaningful increase in the risk of congenital malformations overall, as shown in a study.

Z-drug exposure during early pregnancy not a risk factor for congenital malformations

CHD subtypes linked to increased risk of low Apgar scores in newborns

14 Jan 2026 bởi

According to a study, several congenital heart defect (CHD) subtypes are associated with an elevated risk of low Apgar scores at 5 mins after birth in newborns.

CHD subtypes linked to increased risk of low Apgar scores in newborns

Omega-3 fatty acid supplementation does nothing for youths with depression

13 Jan 2026

In the treatment of children and adolescents with major depressive disorder (MDD), adjunctive supplementation with omega-3 fatty acid does not appear to significantly improve outcomes compared with placebo, according to study.

Omega-3 fatty acid supplementation does nothing for youths with depression

13 Jan 2026

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-December-2025

New drug applications approved by US FDA as of 1-15 December 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-December-2025

Original New Drug Application Approvals by US FDA (16-31 December 2025)

New drug applications approved by US FDA as of 16-31 December 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 December 2025)

Adequate sleep helps prevent obesity in boys

A recent study suggests interventions for children to help them achieve their recommended sleep duration for weekdays and weekends and thus reduce abdominal and total adiposity, particularly in boys.

Adequate sleep helps prevent obesity in boys

Follow-up care a must for late effects in childhood cancer survivors

05 Jan 2026 bởi

Timely screening is needed to enhance early detection of metabolic health, bone health, and hearing impairment among childhood cancer survivors treated in Singapore, suggests a recent study. Adoption of an exposure-based approach to proactively screen for late effects can reduce biopsychosocial impacts.

Follow-up care a must for late effects in childhood cancer survivors

Maternal prepregnancy BMI predicts cardiometabolic outcomes in offspring

High maternal BMI prior to pregnancy appears to contribute to a BMI increase in their offspring during childhood, reveals a study. Moreover, preterm children are more likely to develop hypertension than their term counterparts.

Maternal prepregnancy BMI predicts cardiometabolic outcomes in offspring